Business Insights
Diagnostic Technologies
Diseases
Point-of-Care Testing
Research & Development
Sign In
Autoimmune
Cancer
Cardiovascular
COVID-19
Health Topics
Infectious
Pancreatic Cysts
Growing AI healthcare market boasts variety of deployments
Population health, workflow improvements, diagnostics, and risk assessment are among the areas where artificial intelligence is already being deployed.
October 13, 2019
Second guessing thyroid cancer test | Artificial intelligence on show | Companies gear up for AACC
Dear LabPulse Member,
July 22, 2019
AI-driven test helps make the call on pancreatic cysts
The test -- dubbed comprehensive cyst, or CompCyst -- incorporates mutation status, loss of heterozygosity, aneuploidy, protein markers, and clinical data. An artificial intelligence algorithm is used to help identify which patients should have surgery and which ones can be followed safely.
July 21, 2019
Simple test of cystic fluid may help spare pancreatic surgeries
In the blinded, retrospective analysis of 169 surgical samples from a range of tertiary referral centers, an enzyme-linked immunosorbent assay (ELISA) for the antibody Das-1 had an accuracy of 95% for identifying high-risk lesions and, therefore, which patients were most appropriate for surgery, reported a team led by Dr. Koushik Das, a Washington University gastroenterologist.
June 6, 2019
Most Popular
Quest launches long-COVID testing panels for consumers
Ohio, Kentucky doctors convicted in scheme to bill Medicaid for unnecessary urinalysis testing
RNA-seq analysis links protein to spread of pancreatic cancer, reveals potential drug target
Point-of-care test developer Proxim Diagnostics obtains strategic investment from BioMérieux
Quest Diagnostics offers suite of services for transplant patients and living donors
Rapid nirmatrelvir treatment in study reduced long-COVID risk
Page 1 of 1